MedTrace Logo

Understanding Patient Preference on Colorectal Cancer Screening Options-PSU

NCT06444542 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 297

Last updated 2026-02-20

No results posted yet for this study

Summary

There are significant barriers to colorectal cancer screening within underserved populations due to the cost, accessibility, and acceptability of screening methods. Patient-friendly approaches that minimize stress and discomfort for the patient are needed to enhance screening compliance and achieve an early diagnosis. The primary aim of this study is to examine whether the availability of a blood-based screening option, which can be done at the point of service and is familiar to patients, will improve patient compliance to recommended CRC screening

Conditions

  • Colo-rectal Cancer

Interventions

BEHAVIORAL

Guardant Shield

Blood-based colorectal cancer screening

Sponsors & Collaborators

  • Guardant Health, Inc.

    collaborator INDUSTRY

  • HealthLinc, Inc

    collaborator UNKNOWN

  • PCC Community Wellness Center

    collaborator UNKNOWN

  • Milton S. Hershey Medical Center

    lead OTHER

Principal Investigators

  • Karen E. Kim, MD · Penn State College of Medicine

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-16
Primary Completion
2025-12-18
Completion
2025-12-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06444542 on ClinicalTrials.gov